The global topical bioadhesives market was valued at USD 349.5 Million in 2022 and is expected to reach USD 1.13 Billion by 2033. The synthetic material with around 57.6% in terms of value share, has topped the global market within the material category in 2022 and is expected to grow at a CAGR of close to 11.0% over the forecast period (2023 to 2033)
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | USD 349.5 Million |
Market Value 2023 | USD 392.5 Million |
Market Value 2033 | USD 1.13 Billion |
CAGR 2023 to 2033 | 11.2% |
Market Share of Top 5 Countries | 52.8% |
The topical bioadhesives market refers to the industry involved in the manufacturing, distribution, and sales of bioadhesive products that are designed to be applied to the skin or mucous membranes for various purposes. Bioadhesives are substances that can adhere to biological tissues, providing a strong and long-lasting bond.
Topical bioadhesives are used in medical, pharmaceutical, and cosmetic applications. They can be used to secure medical devices or medical dressings to the skin, improve drug delivery by maintaining prolonged contact with the target site, and enhance the efficacy of topical formulations by extending the residence time on the skin.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for topical bioadhesives was around 6.1% of the overall USD 5.6 Billion of the global Bioadhesives Market in 2022.
The topical bioadhesives market has witnessed significant growth over the years, driven by advancements in medical technology, increasing demand for wound care products, and the rising prevalence of chronic diseases. The market has benefited from the development of innovative bioadhesive formulations and the expanding applications across various industries.
The rising incidence of chronic wounds, such as pressure sores and diabetic ulcers, is expected to drive the demand for advanced wound care products. Topical bioadhesives play a crucial role in wound closure and promoting healing, leading to a higher adoption rate in the healthcare industry.
The pharmaceutical industry is increasingly focusing on developing transdermal drug delivery systems as an alternative to oral or injectable routes. Topical bioadhesives offer a convenient and effective means of drug delivery through the skin, leading to enhanced patient compliance and improved therapeutic outcomes.
Owed to the above factors, the global market is projected to grow at CAGR of 11.2% in forecasted period.
Topical bioadhesives have traditionally been used in wound care and transdermal drug delivery. However, there is a growing opportunity to explore new applications in various fields such as cosmetics, dermatology, and tissue engineering. Manufacturers have been investing in research and development to create innovative bioadhesive products tailored to specific applications and address emerging market needs.
Personalized medicine and tailored treatments are gaining prominence. Topical bioadhesives can be customized to meet individual patient needs, such as wound size, drug dosage, or specific skin characteristics. Manufacturers are exploring these opportunities to offer customizable bioadhesives through partnerships with healthcare providers or by developing user-friendly systems that allow for on-site customization.
Collaboration with research institutions, healthcare providers, and other industry stakeholders can facilitate the development and adoption of innovative topical bioadhesive products. Partnerships can lead to advancements in product development, clinical validation, and market access. Topical bioadhesives also act as surgical sealants to prevent fluid leakage and seal tissues during surgical procedures. Developing bioadhesives that are effective in different surgical scenarios, such as gastrointestinal, cardiovascular, or orthopedic surgeries, presents a promising opportunity.
All the above factors are likely to provide lucrative growth opportunities to the market players over coming years.
The awareness and understanding of using topical bioadhesives among healthcare professionals, patients, and consumers may be limited. This lack of awareness can hinder the adoption of bioadhesive products, as they may not be considered as a standard treatment option or preferred choice compared to conventional alternatives.
The cost of topical bioadhesive products can be relatively higher compared to traditional wound care products or drug delivery methods. The higher cost may deter healthcare providers, patients, or healthcare systems from adopting these products, particularly in regions with limited healthcare budgets or cost-sensitive markets.
Regulatory approval processes and compliance requirements can pose challenges for manufacturers in terms of time, resources, and costs. Strict regulatory frameworks, safety evaluations, and clinical trials can result in delays in product launches or market entry, affecting the speed of adoption and market penetration.
The USA occupies 27.3% of market share in 2022 globally. The USA invests heavily in research and development in the healthcare sector. This has led to continuous improvement of medical adhesives, including topical bioadhesives, with a focus on better performance, safety, and ease of use. Also, the demand for minimally invasive surgical procedures is on the rise in the USA Topical bioadhesives offer advantages in minimally invasive surgeries, providing secure wound closure without the need for sutures or staples, contributing to their popularity in the market.
Germany on topical bioadhesive in 2022 holds global share of USD 6.9%. Germany maintains rigorous regulatory standards for medical devices and healthcare products. Topical bioadhesives that meet these standards gain credibility and trust among healthcare professionals, enhancing their adoption in clinical practice. Germany is a leading market for cosmetic and aesthetic procedures. Topical bioadhesives are used in various cosmetic applications, including tissue augmentation and scar reduction, which adds to their market demand.
In 2022, the India held a global share of 6.9% in 2022. India has become a popular destination for medical tourism, including surgical procedures. With a surge in foreign patients seeking medical treatments in India, there is an opportunity for topical bioadhesive manufacturers to cater to this market. Topical bioadhesives can offer cost-effective solutions for wound closure and surgical procedures, which is especially important in a country like India, where affordability of healthcare is a significant consideration.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By material, synthetic segment held 57.6% market share in world in 2022.
Synthetic materials used in topical bioadhesives offer improved adhesive properties compared to natural materials. They can provide stronger and more durable adhesion to biological tissues, ensuring better wound closure and secure attachment of medical devices or dressings to the skin. Synthetic materials offer versatility in optimizing adhesive strength based on specific application requirements.
Short term application of topical bioadhesives led the global market with 69.9% in 2022. Topical bioadhesives offer a convenient and user-friendly application method. They can be quickly and easily applied to the desired area without the need for complex procedures or specialized medical training. This convenience appeals to both healthcare professionals and patients, leading to increased adoption and market growth. The application of topical bioadhesives for wound closure or securing medical devices can significantly reduce procedure time compared to traditional methods such as sutures or staples. This time-saving benefit is particularly advantageous in emergency departments, outpatient settings, and situations where efficiency and prompt treatment are crucial.
The hospital pharmacies has a considerable presence in the topical bioadhesives market, accounting for 43.4% value share in 2022. Hospital pharmacies are responsible for dispensing medications and medical products to healthcare providers within the hospital setting. They play a crucial role in distributing topical bioadhesive products to various departments and units where they are needed. The availability and easy-accessibility of bioadhesive products through hospital pharmacies contribute to their adoption and market growth.
Collaborations and acquisition between healthcare providers, research facilities, and technology companies can promote creativity and speed the development of topical bioadhesives. Collaboration in research, development, and commercialization can result in new applications and a larger market. The topical bioadhesives market is dominated by numerous sizable businesses. Among the well-known players in this field are:
Similarly, recent developments related to the companies manufacturing the topical bioadhesives have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | USD Million for Value |
Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA) |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
Key Market Segments Covered | Material, Application, Distribution Channel, and Region |
Key Companies Profiled | Ellsworth Adhesives; Henkel Adhesives Technologies India Private Limited; Arkema; Ashland; EcoSynthetix; The Lubrizol Corporation; Camurus AB; Medtronic Plc; B Braun Melsungen Ag; Advanced Medical Solutions Group plc; DERMGLU; VYGON (United Kingdom) LTD; Baxter International; Meyer-Haake |
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Pricing | Available upon Request |
The worldwide topical bioadhesives market is valued at USD 392.5 million in 2023.
Ellsworth Adhesives, Henkel Adhesives Technologies India Private Limited, and Arkema are the leading industry players.
The industry is set to surge at a CAGR of 11.2% from 2023 to 2033.
The synthetic segment is likely to lead the market through 2033.
Growing trend of personalized medicines is expected to fuel the market growth.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Material 7.1. Synthetic 7.1.1. Silicone 7.1.2. Epoxy 7.1.3. Acrylic 7.1.4. Polyurethane 7.2. Natural 7.2.1. Cellulose 7.2.2. Starch 7.2.3. Natural Gum 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 8.1. Short Term 8.2. Long Term 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel 9.1. Hospital Pharmacies 9.2. Retail Pharmacies 9.3. Online Pharmacies 9.4. Drug Stores 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. East Asia 10.5. South Asia 10.6. Oceania 10.7. Middle East and Africa (MEA) 11. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. Market Structure Analysis 19. Competition Analysis 19.1. Ellsworth Adhesives 19.2. Henkel Adhesives Technologies India Private Limited 19.3. Arkema 19.4. Ashland 19.5. EcoSynthetix 19.6. The Lubrizol Corporation 19.7. Camurus AB 19.8. Medtronic Plc 19.9. B Braun Melsungen Ag 19.10. Advanced Medical Solutions Group plc 19.11. DERMGLU 19.12. VYGON (United Kingdom) LTD 19.13. Baxter International 19.14. Meyer-Haake 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports